Dissecting the molecular puzzle of the editosome core in Arabidopsis organelles.

Autor: Baudry K; Université Paris-Saclay, CNRS, INRAE, Université Evry, Institute of Plant Sciences Paris-Saclay (IPS2), Gif sur Yvette 91190, France; Université Paris Cité, CNRS, INRAE, Institute of Plant Sciences Paris-Saclay (IPS2), Gif sur Yvette 91190, France. Electronic address: kb566@cornell.edu., Monachello D; Université Paris-Saclay, CNRS, INRAE, Université Evry, Institute of Plant Sciences Paris-Saclay (IPS2), Gif sur Yvette 91190, France; Université Paris Cité, CNRS, INRAE, Institute of Plant Sciences Paris-Saclay (IPS2), Gif sur Yvette 91190, France., Castandet B; Université Paris-Saclay, CNRS, INRAE, Université Evry, Institute of Plant Sciences Paris-Saclay (IPS2), Gif sur Yvette 91190, France; Université Paris Cité, CNRS, INRAE, Institute of Plant Sciences Paris-Saclay (IPS2), Gif sur Yvette 91190, France., Majeran W; Université Paris-Saclay, CNRS, INRAE, Université Evry, Institute of Plant Sciences Paris-Saclay (IPS2), Gif sur Yvette 91190, France; Université Paris Cité, CNRS, INRAE, Institute of Plant Sciences Paris-Saclay (IPS2), Gif sur Yvette 91190, France., Lurin C; Université Paris-Saclay, CNRS, INRAE, Université Evry, Institute of Plant Sciences Paris-Saclay (IPS2), Gif sur Yvette 91190, France; Université Paris Cité, CNRS, INRAE, Institute of Plant Sciences Paris-Saclay (IPS2), Gif sur Yvette 91190, France. Electronic address: claire.lurin@inrae.fr.

Publikováno v: Plant science : an international journal of experimental plant biology [Plant Sci] 2024 Jul; Vol. 344, pp. 112101. Date of Electronic Publication: 2024 Apr 17.

Analysis of the Plant Mitochondrial Transcriptome.

Autor: Baudry K; Institute of Plant Sciences Paris-Saclay (IPS2), Orsay, France., Delannoy E; Institute of Plant Sciences Paris-Saclay (IPS2), Orsay, France., Colas des Francs-Small C; ARC Centre of Excellence for Plant Energy Biology, The University of Western Australia, WA Crawley, Australia. catherine.colasdesfrancs-small@uwa.edu.au.

Publikováno v: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2022; Vol. 2363, pp. 235-262.

Analyzing Multifactorial RNA-Seq Experiments with DicoExpress.

Autor: Baudry K; Université Paris-Saclay, CNRS, INRAE, Univ Evry, Institute of Plant Sciences Paris-Saclay (IPS2), Orsay, France; Université de Paris, CNRS, INRAE, Institute of Plant Sciences Paris Saclay (IPS2), Orsay, France; Université Paris-Saclay, INRAE, CNRS, AgroParisTech, GQE - Le Moulon, Gif-sur-Yvette, France., Paysant-Le Roux C; Université Paris-Saclay, CNRS, INRAE, Univ Evry, Institute of Plant Sciences Paris-Saclay (IPS2), Orsay, France; Université de Paris, CNRS, INRAE, Institute of Plant Sciences Paris Saclay (IPS2), Orsay, France., Colella S; LSTM, Univ Montpellier, INRAE, IRD, CIRAD, Institut Agro, Montpellier, France., Castandet B; Université Paris-Saclay, CNRS, INRAE, Univ Evry, Institute of Plant Sciences Paris-Saclay (IPS2), Orsay, France; Université de Paris, CNRS, INRAE, Institute of Plant Sciences Paris Saclay (IPS2), Orsay, France., Martin ML; Université Paris-Saclay, CNRS, INRAE, Univ Evry, Institute of Plant Sciences Paris-Saclay (IPS2), Orsay, France; Université de Paris, CNRS, INRAE, Institute of Plant Sciences Paris Saclay (IPS2), Orsay, France; Universitté Paris-Saclay, AgroParisTech, INRAE, UMR MIA-Paris, Paris, France; marie-laure.magniette@inrae.fr.

Publikováno v: Journal of visualized experiments : JoVE [J Vis Exp] 2022 Jul 29 (185). Date of Electronic Publication: 2022 Jul 29.

Clinical practice guidelines for BRCA1 and BRCA2 genetic testing.

Autor: Pujol P; Department of Cancer Genetics, CHU Montpellier, Univ Montpellier, Montpellier, France; CREEC, UMR IRD 224-CNRS 5290 Université Montpellier, Montpellier, France. Electronic address: p-pujol@chu-montpellier.fr., Barberis M; Pathology Unit, European Institute of Oncology, Milan, Italy. Electronic address: Massimo.barberis@ieo.it., Beer P; Wellcome Trust Sanger institute, Cambridge, United Kingdom; Glasgow Precision Oncology Laboratory, United Kingdom. Electronic address: pbeer@doctors.org.uk., Friedman E; The Susanne Levy Gertner Oncogenetics Unit, Chaim Sheba Medical Center, Ramat Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel. Electronic address: Eitan.Friedman@sheba.health.gov.il., Piulats JM; Unidad Funcional de Cáncer de Próstata, Servicio de Oncología Médica, Hospital Universitari de Bellvitge-Institut Català d'Oncologia (ICO), Hospitalet de Llobregat, Spain; Servicio de Oncología Médica, Institut Català d'Oncologia (ICO), Hospitalet de Llobregat, Spain. Electronic address: jmpiulats@iconcologia.net., Capoluongo ED; Dipartimento di Medicina Molecolare e Biotecnologie Mediche Università Federico II, CEINGE Biotecnologie Avanzate, Naples, 80145, Italy. Electronic address: ettoredomenico.capoluongo@unina.it., Garcia Foncillas J; Translational Oncology Division, Oncohealth Institute, IIS-Fundación Jimenez Diaz-UAM, Madrid, Spain. Electronic address: jesus.garciafoncillas@oncohealth.eu., Ray-Coquard I; Oncologie Médicale, Centre Leon Bérard; Univ Lyon, Université Claude Bernard Lyon1, Hesper EA 7425, F - 69003, Lyon, France. Electronic address: Isabelle.Ray-Coquard@lyon.unicancer.fr., Penault-Llorca F; Department of Biology and Pathology, Centre Jean Perrin, Clermont Ferrand, France; UMR INSERM 1240, Université Clermont Auvergne, Clermont Ferrand, France. Electronic address: Frederique.PENAULT-LLORCA@cjp.fr., Foulkes WD; McGill University, Division of Medical Genetics, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada. Electronic address: william.foulkes@mcgill.ca., Turnbull C; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK; Genomics England, Queen Mary University of London, London, UK; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, UK. Electronic address: Clare.Turnbull@genomicsengland.co.uk., Hanson H; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. Electronic address: helen.hanson@icr.ac.uk., Narod S; University of Toronto Dalla Lana School of Public Health, Toronto, ON, Canada; Canada Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada. Electronic address: Steven.Narod@wchospital.ca., Arun BK; Anderson Cancer Center, The University of Texas, Department of Breast Medical Oncology, Division of Cancer Medicine, USA. Electronic address: barun@mdanderson.org., Aapro MS; IMO Clinique de Genolier, Genolier, Switzerland. Electronic address: Maapro@genolier.net., Mandel JL; Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France; Université de Strasbourg, Illkirch, France. Electronic address: jlmandel@igbmc.fr., Normanno N; Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy. Electronic address: n.normanno@istitutotumori.na.it., Lambrechts D; Laboratory of Translational Genetics (VIB-KU Leuven), ON IV Herestraat 49 - box 912, 3000, Leuven Belgium. Electronic address: diether.lambrechts@kuleuven.vib.be., Vergote I; Department of Gynaecologic Oncology University Hospitals Leuven, Gasthuisberg Herestraat 49, 3000 Leuven, Belgium. Electronic address: ignace.vergote@uzleuven.be., Anahory M; Pech de Laclause, Bathmanabane & Associés Law Firm, Paris, France. Electronic address: manahory@pechdelaclause.com., Baertschi B; French National Institute for Health and Medical Research (INSERM) Ethics Committee, France University of Geneva, Geneva, Switzerland. Electronic address: bernard.baertschi@unige.ch., Baudry K; Department of Cancer Genetics, CHU Montpellier, Univ Montpellier, Montpellier, France. Electronic address: k-baudry@chu-montpellier.fr., Bignon YJ; Department of Oncogenetics, Centre Jean Perrin, CBRV, Clermont-Ferrand, France; INSERM-U1240-Molecular Imaging and Theranostic Strategies (IMOST), Clermont-Ferrand, France. Electronic address: Yves-Jean.Bignon@cjp.fr., Bollet M; Institut Hartmann, 4, rue Kléber, et Institut Rafael, 3 bd Bineau, 92309 Levallois-Perret cedex, France. Electronic address: marc.bollet@horg.fr., Corsini C; Department of Cancer Genetics, CHU Montpellier, Univ Montpellier, Montpellier, France. Electronic address: c-corsini@chu-montpellier.fr., Cussenot O; CeRePP, Hopital Tenon, Paris, France; Sorbonne Université, Institut Universitaire de Cancérologie, GRC n°5 ONCOTYPE-URO, Hopital Tenon, APHP, Paris, France; Department of Urology, Assistance Publique- Hôpitaux de Paris, Hopital Tenon, Paris, France. Electronic address: olivier.cussenot@tnn.aphp.fr., De la Motte Rouge T; Inserm, Oncogenesis, Stress and Signaling, 35000 Rennes, France; Service d'oncologie médicale, CRLCC Eugène-Marquis, 35000 Rennes, France; UMR 1242, Inserm, Univ Rennes, CLCC Eugène Marquis, Rue Bataille Flandres Dunkerque, 35042, Rennes, France. Electronic address: t.delamotterouge@rennes.unicancer.fr., Duboys de Labarre M; Department of Cancer Genetics, CHU Montpellier, Univ Montpellier, Montpellier, France. Electronic address: m-duboysdelabarre@chu-montpellier.fr., Duchamp F; Department of Cancer Genetics, CHU Montpellier, Univ Montpellier, Montpellier, France. Electronic address: f-duchamp@chu-montpellier.fr., Duriez C; BRCA France Association, France. Electronic address: duriez.clarisse@gmail.com., Fizazi K; Institut Gustave Roussy and University of Paris Sud, Villejuif, France. Electronic address: karim.FIZAZI@gustaveroussy.fr., Galibert V; Department of Cancer Genetics, CHU Montpellier, Univ Montpellier, Montpellier, France. Electronic address: v-galibert@chu-montpellier.fr., Gladieff L; Department of Medical Oncology, Institut Claudius Regaud, IUCT-O, Toulouse, France. Electronic address: Gladieff.Laurence@iuct-oncopole.fr., Gligorov J; APHP-Tenon, IUC-UPMC, Sorbonne University, Paris, France. Electronic address: joseph.gligorov@aphp.fr., Hammel P; Department of Pancreatology, Hôpital Beaujon (AP-HP), Université Denis Diderot-Paris VII, Clichy, France. Electronic address: pascal.hammel@bjn.aphp.fr., Imbert-Bouteille M; Department of Cancer Genetics, CHU Montpellier, Univ Montpellier, Montpellier, France. Electronic address: m-imbert-bouteille@chu-montpellier.fr., Jacot W; Department of Medical Oncology, Institut du Cancer de Montpellier (ICM), Univ. Montpellier, 208 rue des Apothicaires, 34298, Montpellier Cedex 5, France; Translational Research Unit, Institut du Cancer de Montpellier (ICM), Univ. Montpellier, Montpellier, France. Electronic address: William.Jacot@icm.unicancer.fr., Kogut-Kubiak T; Department of Cancer Genetics, CHU Montpellier, Univ Montpellier, Montpellier, France. Electronic address: t-kogutkubiak@chu-montpellier.fr., Lamy PJ; Institut d'analyse génomique-Imagenome, Labosud, Montpellier, France. Electronic address: pierre-jean.lamy@labosud.fr., Nambot S; Centre de Génétique et Centre de Référence Maladies Rares (Anomalies du Développement de l'Interrégion Est), Hôpital d'Enfants, CHU Dijon Bourgogne, Dijon, France; Inserm UMR 1231 GAD (Génétique des Anomalies du Développement), Université de Bourgogne, Dijon, France; Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (FHU TRANSLAD), CHU Dijon Bourgogne et Université de Bourgogne-Franche Comté, Dijon, France. Electronic address: sophie.nambot@chu-dijon.fr., Neuzillet Y; Service d'urologie et de transplantation rénale, hôpital Foch, université de Versailles - Saint-Quentin-en-Yvelines, 40, rue Worth, 92150 Suresnes, France. Electronic address: y.neuzillet@hopital-foch.org., Olschwang S; Aix Marseille Université, INSERM GMGF UMR 1251, France; Département de Génétique Médicale, Hôpital Européen & Groupe Ramsay Générale de Santé, Hôpital Clairval, Aix Marseille Université, Marseille, France. Electronic address: solschwang@gmail.com., Rebillard X; Service d'Urologie, Clinique Beausoleil, Montpellier, France. Electronic address: xavier.rebillard@wanadoo.fr., Rey JM; Department of Cancer Genetics, CHU Montpellier, Univ Montpellier, Montpellier, France. Electronic address: jm-rey@chu-montpellier.fr., Rideau C; Department of Cancer Genetics, CHU Montpellier, Univ Montpellier, Montpellier, France. Electronic address: c-rideau@chu-montpellier.fr., Spano JP; Department of Medical Oncology, Hôpital Pitié Salpêtrière, APHP, Sorbonne Université, Paris, France; Inserm UMRS 1136, Sorbonne Université, Paris, France. Electronic address: jean-philippe.spano@psl.aphp.fr., Thomas F; IRD, CREEC et MIVE911 avenue Agropolis, BP 64501, Montpellier 34 394, France. Electronic address: frederic.thomas2@ird.fr., Treilleux I; Department of Pathology, Centre Léon Bérard, 28 rue Laënnec, 69373, Lyon Cédex 08, France. Electronic address: isabelle.treilleux@lyon.unicancer.fr., Vandromme M; BRCA France Association, France. Electronic address: marion.vandromme@gmail.com., Vendrell J; IRCM, INSERM 1194, Department of Pathology and Oncobiology, Laboratoire de biologie des tumeurs solides, CHU Montpellier, Univ Montpellier, Montpellier, France. Electronic address: j-vendrell@chu-montpellier.fr., Vintraud M; Department of Radiotherapy, Hartmann Radiotherapy Center, Levallois-Perret, France. Electronic address: michelevintraud@live.fr., Zarca D; The Paris Breast Centre- L'Institut Français du Sein- 15 rue Jean Nicot, 75007, Paris, France. Electronic address: daniel.zarca@gmail.com., Hughes KS; Division of Surgical Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: kshughes@partners.org., Alés Martínez JE; Medical Oncology Department, Hospital Nuestra Señora de Sonsoles, Ávila, Ávila, Spain. Electronic address: jealesm@yahoo.es.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Mar; Vol. 146, pp. 30-47. Date of Electronic Publication: 2021 Feb 10.

Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial

Autor: Lemonnier, J., Roca, L., Mijonnet, S., Gesta, P., Chiesa, J., Dreyfus, H., Vennin, P., Delnatte, C., Bignon, Y. J., Lortholary, A., Prieur, F., Gladieff, L., Lesur, A., Clough, K. B., Nogues, C., Martin, A-L., Centres, On behalf the French Fedration of Cancer, Pujol, P., Lasset, Christine, Berthet, P., Dugast, C., Delaloge, S., Fricker, J-P., Tennevet, I., Chabbert-Buffet, N., This, P., Baudry, K.

Publikováno v: Familial Cancer
Familial Cancer, 2012, 11, pp.77-84. ⟨10.1007/s10689-011-9484-4⟩

Women with germline BRCA1 or BRCA2 (BRCA1/2) mutations are considered as an extreme risk population for developing breast cancer. Prophylactic mastectomy provides a valid option to reduce such risk, impacting however, the quality of life. Medical pre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52ad1c49c845f41799322512ae372749
https://pubmed.ncbi.nlm.nih.gov/22076253